Autoimmune disorders, characterized by the immune system mistakenly attacking the body's own tissues, are increasingly recognized for their significant impact on cardiovascular health, often through chronic inflammation.

The Autoimmune-Heart Connection

Autoimmune diseases occur when the body's immune system, which normally fights off infections, mistakenly targets and damages its own healthy tissues [1]. A growing body of research indicates a strong link between these conditions and an increased risk of cardiovascular disease [6]. This connection is evident even in childhood, with conditions like juvenile systemic lupus erythematosus, juvenile dermatomyositis, and juvenile idiopathic arthritis showing early signs of elevated cardiovascular risk [2]. The underlying mechanisms often involve chronic inflammation, endothelial dysfunction (damage to the lining of blood vessels), and shared genetic predispositions [2, 6].

Inflammation: A Key Driver of Heart Damage

Chronic inflammation is a central factor linking autoimmune diseases to heart problems [2, 3]. While a normal inflammatory response is crucial for healing and protection, a persistent, pathological autoimmune response can lead to serious heart issues [1]. This sustained inflammation can contribute to the stiffening and scarring of heart tissue, known as cardiac fibrosis, which is a common event in many diseases causing heart arrhythmias [3].

The immune system's components, such as B cells, can also play a direct role. For instance, in conditions like atrial fibrillation (AF), the most common cardiac arrhythmia, B cells can produce autoantibodies that interfere with how heart muscle cells handle calcium, potentially leading to irregular heartbeats [7]. Studies have shown that depleting B cells or plasma cells can reduce AF in animal models [7]. Furthermore, specific inflammatory and anti-inflammatory signaling molecules, called cytokines, are implicated in various heart conditions, including right heart disease and AF [3].

Specific Heart Conditions and Autoimmunity

Myocardial Infarction (Heart Attack): While rare in children, myocardial infarction has been reported in pediatric patients with systemic lupus erythematosus (SLE) [4]. In adults, an immune response is associated with heart attacks, and a pathological autoimmune response can lead to ventricular remodeling (changes in the heart's shape and function) and heart failure [1]. Genetic studies have also identified shared genetic architecture between autoimmune diseases and myocardial infarction risk [6].
Atrial Fibrillation (AF): This common arrhythmia, which increases the risk of stroke and sudden death, is strongly linked to inflammation and cardiac fibrosis [3]. Autoantibodies produced by B cells have been shown to disrupt heart cell function, contributing to AF [7].
Right Heart Disease: Characterized by structural changes and dysfunction of the right ventricle and atrium, right heart disease is a significant risk factor for AF [3]. Autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and juvenile idiopathic arthritis can lead to alterations in right ventricular contractility, increasing cardiovascular risk [8].
Rheumatic Heart Disease (RHD): This condition develops after untreated Streptococcus pyogenes throat infections, primarily in children with specific genetic susceptibilities [5]. It's an autoimmune reaction where the immune system mistakenly attacks heart tissue due to molecular mimicry between bacterial proteins and human proteins, leading to carditis and severe heart valve damage [5].

Autoimmune Conditions and Their Cardiac Impact

Many systemic autoimmune diseases have been observed to impact heart health:

Systemic Lupus Erythematosus (SLE): Children with SLE face an increased risk of cardiovascular disease [2]. SLE can also lead to severe events like myocardial infarction, even in pediatric cases [4].
Rheumatoid Arthritis (RA): Patients with RA may experience alterations in right ventricular contractility, contributing to a higher cardiovascular risk [8].
Systemic Sclerosis (SSc): This condition is particularly associated with changes in the right ventricle, often due to pulmonary arterial hypertension, which is a leading cause of death in SSc patients [8].
Juvenile Idiopathic Arthritis (JIA) and Juvenile Dermatomyositis (JDM): Both conditions are associated with an increased risk of cardiovascular disease in children [2].

The exact causes of these heart alterations in many autoimmune diseases are still under investigation, but small vessel damage and fibrosis due to subclinical inflammation are considered likely contributors [8].

Looking Ahead: Managing Risk and Future Therapies

Given the complex interplay between autoimmune diseases and heart health, a comprehensive approach to care is essential. For individuals with autoimmune conditions, managing disease activity and monitoring cardiovascular risk factors are crucial [2].

Research is actively exploring new therapeutic strategies. Regulating immune function, for example, may become a new target for preventing heart failure after a heart attack [1]. For conditions like atrial fibrillation, investigating key inflammatory and fibrosis agents could lead to new treatments that complement existing management strategies [3]. B-cell depletion, a clinical tool used in some autoimmune diseases, has shown promise in reducing atrial fibrillation in animal models [7]. Furthermore, the development of vaccines, such as those targeting S. pyogenes, holds potential to prevent rheumatic heart disease [5]. Pharmacologic and nonpharmacologic interventions are also continually being sought to improve long-term cardiovascular outcomes in children with rheumatic diseases [2].

Sources

[1] Autoimmunity in myocardial infarction. https://pubmed.ncbi.nlm.nih.gov/16837084/
[2] Cardiovascular Health in Pediatric Rheumatologic Diseases. https://pubmed.ncbi.nlm.nih.gov/34798945/
[3] Pro- and Anti-Inflammatory Cytokines' Implication in Right Heart Disease, Arrhythmogenesis, and Atrial Fibrillation. https://pubmed.ncbi.nlm.nih.gov/41750286/
[4] Myocardial infarction in a child with systemic lupus erythematosus. https://pubmed.ncbi.nlm.nih.gov/41763661/
[5] Rheumatic Heart Disease: Pathogenesis and Vaccine. https://pubmed.ncbi.nlm.nih.gov/28745221/
[6] Genome-wide cross-trait analysis reveals immunogenetic pleiotropy between autoimmune diseases and myocardial infarction and prioritizes therapeutic targets. https://pubmed.ncbi.nlm.nih.gov/42462659/
[7] B cells promote atrial fibrillation via autoantibodies. https://pubmed.ncbi.nlm.nih.gov/41062615/
[8] Right Ventricle and Autoimmune Diseases. https://pubmed.ncbi.nlm.nih.gov/37861019/

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.